Insights · July 17, 2026
By Mason Hughes
Most AI rollouts don't fail because the model was wrong. They fail because the tool showed up before anyone mapped what the business actually needed it to fix. Buying the seats is the easy part. Sequencing is the part nobody budgets for.
The tool arrives first: a subscription, a pilot, seats for the whole team, and then everyone waits for something useful to happen. Without a mapped operation underneath it, the AI has nothing specific to attach to, so it gets used for a handful of small tasks and quietly stops being worth the line item.
Existing tools aren't wasted, they're just missing the layer underneath them. We map the operation first, find where the actual constraint is, and then point your existing subscriptions at that specific problem instead of leaving them general-purpose and mostly idle.
No. The Operational Health Assessment runs in a matter of days, not months; it's a diagnostic, not a redesign. The sequencing isn't slower, it's just ordered: diagnose the constraint, then bring in the tool built for that constraint, instead of the other way around.
A map of where the operation is constrained or leaking, tied to your ten core business capabilities, guided by the Data Fence that keeps that mapping safe. Only once that's built does a specific tool, AI or otherwise, get recommended, and only where the diagnosis says it earns its place.
20 Questions · 5 Minutes
45 Minutes · Free